Secondary Logo

Journal Logo

Articles by Ikuo Hirano, M.D.

A Randomized, Double-Blind, Placebo-Controlled Trial of a Novel Recombinant, Humanized, Anti-Interleukin-13 Monoclonal Antibody (RPC4046) in Patients with Active Eosinophilic Esophagitis: Results of the HEROES Study: 420

Dellon, Evan S.; Collins, Margaret; Assouline-Dayan, Yehudith; More

American Journal of Gastroenterology. 111:S186, October 2016.

How Do Gastroenterologists Assess Overall Activity of Eosinophilic Esophagitis in Adult Patients?

Schoepfer, Alain M; Panczak, Radoslaw; Zwahlen, Marcel; More

American Journal of Gastroenterology. 110(3):402-414, March 2015.